Sentences with phrase «human vaccine companies»

Anne T, the human vaccine companies have a lot of experience working with flu, and with manufacturing human flu vaccines.

Not exact matches

The company has begun human testing of its mRNA drugs for cardiovascular disease and cancer, and for vaccines against the flu, Zika, and chikungunya viruses.

Vaccines developed using proteins rather than live viruses can help protect animals and subsequently humans from insect - borne viruses, according to Alan Young, chief scientific officer for Medgene Labs, an animal health company that develops therapeutics and diagnostics, including vVaccines developed using proteins rather than live viruses can help protect animals and subsequently humans from insect - borne viruses, according to Alan Young, chief scientific officer for Medgene Labs, an animal health company that develops therapeutics and diagnostics, including vaccinesvaccines.

The method is relatively new, but far bacteria - based vaccines have proven effective: A seasonal flu vaccine produced by VaxInnate successfully protected humans in clinical trials, and the company's recently tested swine flu vaccine immunized mice against the virus.

July 2016: Two human vaccine trials begin, one led by the U.S. National Institutes of Health and a second by U.S. company Inovio Pharmaceuticals and South Korean firm GeneOne.

Already scientists at Human Genome Sciences in Rockville, Maryland — a biotech company affiliated with Venter's research institute — have begun working on a more effective vaccine against Haemophilus.

A promising sign, Fu says, is that at least 15 companies are now producing human rabies vaccines for as low as $ 15 per dose through modern techniques.

At a meeting in Geneva this week, the WHO asked pharmaceutical companies and governments for more antiviral drugs and ordinary flu vaccine to prevent chicken handlers being infected by human flu at the same time as bird flu.

«In line with our company's commitment to address global health needs, we are committed to working with leading experts to develop a preventative HIV vaccine and our team is excited to advance this program into human clinical studies.»

Cytos, a biotechnology company outside of Zurich, Switzerland, is testing a different antighrelin vaccine in a clinical trial of 112 obese humans; results, says Martin Bachmann, Cytos's chief scientific officer, will be available in November.

Pigs will be tested at different developmental stages using adjuvants that are commercially available and / or undergoing evaluation, from human and veterinary vaccine companies.

Baltimore biotechnology company Profectus BioSciences is testing a vaccine to guard against the Ebola virus on 39 human subjects, a first step toward administering it more broadly to people at risk of exposure to the deadly pathogen.

In 2005, Dan co-founded and served as President and CEO of Inviragen Inc., which he transformed from a virtual start - up to a global clinical stage company with sites in Colorado, Wisconsin and Singapore and translated two vaccines from the research bench to human clinical trials, including one for dengue fever.

• Pharmaceutical: Human pharmaceutical and vaccine products marketed either directly by the company or through joint ventures.

Sinovac Biotech, Ltd. is a fully integrated, profitable China - based biopharmaceutical company that focuses on the research, development, manufacturing and commercialization of vaccines that protect against human infectious diseases.

Sinovac Biotech Ltd. is biopharmaceutical company that focuses on research, development, manufacturing and commercialization of vaccines that protect against human infectious diseases including hepatitis A and B, seasonal influenza, H5N1 pandemic influenza and mumps, as well as animal rabies vaccine.

In dogs it has been demonstrated that when intranasal Bordetella bronchiseptica vaccines are used for initial vaccination and injectable vaccines are used for subsequent doses, immune responses may be improved.3, 4 Similar techniques combining oral and injectable vaccines have been demonstrated to provide a more robust immune response in humans.5 Zoetis is excited to be the only company to offer veterinarians the capability to use this concept for vaccination of their canine patients against B.bronchiseptica.